Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Classy guy
Thankfully you’re not running the company as you obviously can’t or don’t read. You’re trying too hard and obviously don’t have any long position as all your posts have a negative slant (I reviewed them)
Any upward move is positive as it gives increased transparency. Obviously that’s a negative for you so no need for you to hang around this company as management isn’t up to your standard
Again I ask you where’s the negative of going to a higher tier while waiting on nasdaq? “What will people think” isn’t an argument
I agree with the message you sent however, many small steps make big moves. A QX to Nasdaq jump is a much easier move than pink to Nasdaq move and much easier for Nasdaq to stomach.
QX will not mean more buying as funds etc can’t touch it nor brokers recommend however it has to be seen as a positive step given how long this process has taken.
Why not make it easier for nasdaq to say yes when we are still waiting?
I’ll try this one more time for the slow learners at the back of the room.
Nasdaq and any otc move aren’t connected
They run independently.
If there was anything negative from nasdaq, the company would have to report that within 73 hours therefore it’s still in process.
Nasdaq process is just that, a process. Question , answer until the end, then they make their decision.
Any move to a more transparent exchange with the orcbb or QX is is, has to be welcomed.
It’s not about more people buying, it’s about doing the right thing. Like adding Deloitte. All little steps add up
To big moves
Whet a load of BS . It’s a stupid response
The lack of insight and just common sense from some of you guys is baffling. Please explain how, while waiting on nasdaq, a move off the pinks is in any way negative
All the advantages of the QX. Maybe you could provide the negatives to going to a more transparent exchange?
What is the OTCQX?
The OTCQX is the top tier of the three marketplaces for the over-the-counter trading of stocks. The OTCQX is provided and operated by the OTC Markets Group. Stocks that trade on this forum must meet more stringent qualification criteria compared to the other tiers.
Penny stocks, shell companies, and companies in bankruptcy cannot qualify for a listing on the OTCQX.
Understanding OTCQX
The over-the-counter (OTC) market is a decentralized market where securities, not listed on major exchanges, are traded directly by a network of dealers. Instead of providing an order matchmaking service as with the NYSE, these dealers carry inventories of securities to facilitate any buy or sell orders.
The OTCQX roster, also called the OTCQX Best Market, includes a large number of blue chip stocks from Europe, Canada, Brazil, and Russia. These large foreign stocks are frequently global household names.
Regulation of OTCQX
Companies trading on the OTCQX must follow standards to improve transparency. The OTCQX excludes companies that are most likely to be associated with stock promoters and other shady operations. The OTCQX sets standards that a company must meet for inclusion. A company must meet high financial standards, be current in its disclosure, and have sponsorship from a professional third-party advisor. Listed companies report to a U.S. regulator such as the Securities and Exchange Committee (SEC) or the Federal Deposit Insurance Corporation (FDIC).
The OTCQX marketplace is run by OTC Link, an electronic inter-dealer quotation and trading system developed by OTC Markets Group. OTC Link is registered with the SEC as a broker-dealer and also as an alternative trading system (ATS). OTC Link enables broker-dealers to not only post and disseminate their quotes, but to also negotiate trades through the system’s electronic messaging capability. This feature allows it to replace the Over-the-Counter Bulletin Board (OTCBB), which was a quotation-only system.
The OTCQX Marketplace provides some advantages to investors. It separates out the superior companies from the numerous OTC companies that are financially challenged, those involved in questionable activities, or both. It enables investors to participate in the growth of foreign blue chips. Investors may view real-time Level 2 quotes with detailed market data and market depth.
All broker-dealers that trade OTCQX, OTCQB, and OTC Pink securities have to be Financial Industry Regulatory Authority (FINRA) members. Further, they must register with the SEC and are subject to state securities regulations. In this way, as with exchange-traded securities, investors trading OTC securities are protected from an unethical broker-dealer’s illegal practices by the same SEC and FINRA rules such as Best Execution, Limit Order Protection, Firm Quotes, and Short Position Disclosure.
The company has gotten bad advice for too long. A QB or QX move makes perfect sense as it increases transparency and would make it easier for Nasdaq. As for costing, 15-20k is irrelevant if it moves the company on
This is really positive developments. I think a QX move would be followed very quickly with the full Nasdaq uplist. At that point, the company can qualify for big funds and etfs plus analysts coverage.
Tick tock, it’s all coming
That I can’t comment on, why is where somebody be on vacation relevant ? Seems peculiar?
Just really bad taste with that comment
Just reviewed the board again and as I thought, all Directors are US based
Multiples are pointless in an emerging life sciences arena. People only trying to muddy the water. The fact that the company is generating revenues at this stage of its evolution is a positive that most in this space can only dream off.
Here you’re buying the vision and potential and if your buying on short term earnings multiples then you’re in the wrong place
I can assure you 1000000% we will not be on nasdaq next week or the week after. They are never going to uplist any stock below $3. You can all fool yourselves but that’s the facts.
A sensible mine would be onto QB/QX for great transparency as a stepping stone to Nasdaq. I believe we will see Nasdaq but in the steps above and over $3 pps .
There is Zero chance of Nasdaq next week so let’s all stop the false prophecies that just set people up for disappointment.
Closer than you think! Always darkest before the dawn
Therein lies what Thomas is eluding to! FDA trials on the way
It’s 4.5 months , application went in on form 10 approval which was June 21. Also there are no updates from nasdaq other than approval or denial, they ask questions until they have made a decision but do not issue running commentary.
So given there is no news, the process is still going and the company can’t give an update as they don’t have one
100% legit just too much hype too soon. Going to be a winner
Too many things right for it not to be real
Drown out the bull and bear noises and look at the following
Board is impressive
Relationships with preeclampsia foundation (backed by gates foundation)
Tmo relationship
Awarded asrm award on Wednesday
Attorneys Wilson sonsini
Auditor Deloitte
Excellent experiences management team
New labs
Generation of revenues
Multiple new product launches
Suite of patents
Multiple revenue streams
No debt
Much better company now than when it was at $6-90. It will recover despite all the doom and gloom here
“The sun will come out tomorrow , bet your bottom dollar”
Great idea
Watch out for the falling bits of sky
Now you’re getting why Thomas is excited. Also we haven’t even heard the new data yet !
I’d say sooner than later. Citic run 200 fertility clinics in China. Doesn’t take a lot to see how this happens quickly
600m euro bond confirmation!
https://www.stamdata.com/Public/Issue/SE0004870624
Looks like things are going to crank up here soon! Reading through the different divisions is interesting, this thing will be huge
The global IVF market is expected to reach USD $36.2 billion by 2026 (CAGR 10.2%). PREDs patent portfolio is worth a fortune as is their platform! Add in the PGX plus market which is Billions more and the next 5 years will be fun.
You’re seeing the butterfly effect as we see the company grow into other sectors outside of stem cells
Just so everyone knows.
Fertility DX is the ultimate fertility package out there. Covers the genetic footprint of mum and Dad as well as identifying any potential concerns with fetus pre conception.
Both Artguide and fertility DX being rolled out to 9000 doctors at ASRM this week! Plus 2 main presentations (out of 3) being chaired by pred doctors and also releasing new research.
The jockey provided a vehicle, the framework was provided by the doctors and scientists.
As for the future of the company, it’s clearly laid out in the PRs over the last year. ArtGuide, fertility DX, PGxPLUS and a move away from stem cells. They couldn’t be more clear. It’s also frowned upon for non big board companies to give earnings projections as it’s deemed to be promotional. Management is doing everything by the book.
As for Nasdaq, it will come in its own time. People’s unrealistic timelines fed by rumors are the issue. It’s a process and as such is still running
Your very mistaken about the jockey. The guy you referred to is no longer the driver in PRED. This is being run by attorneys and the pharma teams.
28 pieces of news this year.
Here they all are
http://predtechgroup.com/press/
It was released in a company PR a number of weeks ago.
http://predtechgroup.com/2019/08/predictive-technology-group-announces-launch-of-pgxplus-pharmacogenomic-test-and-reaches-clinical-study-enrollment-milestone/
Dr. Bryt Christensen, M.D., a pain specialist, reports, “The PGxPLUS+ pharmacogenetic test has been very helpful in my day-to-day practice. The results give insights into why some patients are not responding to medications as expected. With the help of these test results, I have been able to start or switch medications for patients more successfully. The PGxPLUS+ test helps me avoid prescribing medications that a patient won’t metabolize well, leading to better and more personalized patient care.”
Here’s his background
Training
Residency: Johns Hopkins University School of Medicine – Baltimore; Physical Medicine and Rehabilitation
Fellowship: Johns Hopkins University School of Medicine – Baltimore; Pain Management
This is the trouble with this board, nobody reads
Also nobody believes you or your friends own millions of shares as anyone that involved would have there homework done, obviously you don’t
Here’s all the other 28 press releases from the last 10 months as well. Might make sense for you and your “big” shareholder friends to read about what you’re pretending you own
http://predtechgroup.com/press/
Go with both just in case as he sounds like he needs them. If nothing else, it will drown out the noise
Hit the nail on the head. Ps, no Santa either as I know you were told that as well! As for the Easter bunny, I’ll leave that as there’s only so much disappointment one person can take
You said it. Dumb
Just like you
Company is not responsibly for your trading strategy’s. It was almost $7 so you could have sold and bought back!
Everyone wants a crutch to blame their actions on. Company is executing, stock up or down isn’t determined by the company. The company also doesn’t decide when somebody buys or sells. That’s down to the individuals. Time everyone took responsibility for their own decisions and not be looking for somebody to make them feel better on a message board
90% of all fertility treatments are cash pay. Nice try though .